1. Dendritic Cell-Based Vaccination in Cancer: Therapeutic Implications Emerging from Murine Models
   Soledad Mac Keon et al, 2015, Frontiers in Immunology CrossRef
2. CC motif chemokine ligand 19 suppressed colorectal cancer in vivo accompanied by an increase in IL-12 and IFN-γ
   Jun Lu et al, 2015, Biomedicine & Pharmacotherapy CrossRef
3. In situ vaccination: Cancer immunotherapy both personalized and off‐the‐shelf
   Linda Hammerich et al, 2015, Molecular Oncology CrossRef
4. Interleukin 12: still a promising candidate for tumor immunotherapy?
   Witold Lasek et al, 2014, Cancer Immunology, Immunotherapy CrossRef
5. Antitumor Effects of IL-12 in Preclinical Studies
   Witold Lasek et al, 2016, Interleukin 12: Antitumor Activity and Immunotherapeutic Potential in Oncology CrossRef
6. In situvaccination for the treatment of cancer
   Linda Hammerich et al, 2016, Immunotherapy CrossRef
7. Immunomodulation Within a Single Tumor Site to Induce Systemic Antitumor Immunity: In Situ Vaccination for Cancer
   Linda Hammerich et al, 2016, Novel Immunotherapeutic Approaches to the Treatment of Cancer CrossRef
8. Interleukin-12 as an in situ cancer vaccine component: a review
   Emily M. Cheng et al, 2022, Cancer Immunology, Immunotherapy CrossRef